Opioids Morphine

PreclinicalSmall molecule

UUniversity of Mississippi Medical Center

Opioids Morphine is one of 3 small molecule programs targeting Peripheral Nerve Block. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Peripheral Nerve BlockTerminated

Peripheral Nerve BlockPreclinical

Terminated

Competition

Competitive Landscape

2 competitors in Peripheral Nerve Block

#DrugCompanyPhaseTrials

Nubain

AAultman Health Foundation

Preclinical

1 2

Local Anesthetic

RRennes University Hospital

Preclinical

1 3

Opioids Morphine

UUniversity of Mississippi Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Peripheral Nerve Block1 trial

Peripheral Nerve Blocks in Pediatric Orthopedic Patients

Terminated·UUniversity of Mississippi Medical Center·N/A·NCT02236130·49 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Opioids Morphine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Opioids Morphine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Opioids Morphine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Mississippi Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Mississippi Medical Center

Opioids Morphine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Peripheral Nerve Block1 trial

References

Drug Info

Quick Facts

Related News